This systematic review and meta‐analysis evaluated the efficacy and safety of the iLet bionic pancreas (iLet BP), a novel automated insulin delivery (AID) system, in managing type 1 diabetes. This evidence concerns the gene INS and type 1 diabetes mellitus.